Cropel Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.75 Cr
- Revenue Growth 1518.14%
- Profit Growth 186.29%
- Ebitda 5312.55%
- Net Worth 6.58%
- Total Assets 134.18%
About Cropel Lifesciences
Cropel Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 August 2020 (Four years and five months 13 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.75 Cr.
Alkesh Sangani, Kishorkumar Kachhadia, Mukeshkumar Vekaria, and Six other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304GJ2020PTC115678
-
Company No.
115678
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Aug 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Cropel Lifesciences?
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukeshkumar Vekaria
|
Director | 29-Mar-2022 | Current |
|
Alkesh Sangani
|
Director | 29-Mar-2022 | Current |
|
Kishorkumar Kachhadia
|
Director | 20-Jul-2022 | Current |
|
Haresh Tadhani
|
Director | 20-Jul-2022 | Current |
|
Prakash Dobariya
|
Director | 29-Mar-2022 | Current |
|
Jayantilal Bhuva
|
Director | 20-Aug-2020 | Current |
Financial Performance of Cropel Lifesciences.
Cropel Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1518.14% increase. The company also saw a substantial improvement in profitability, with a 186.29% increase in profit. The company's net worth moved up by a moderate rise of 6.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cropel Lifesciences?
In 2022, Cropel Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
-
Cropel International Private Limited
Alkesh Sangani, Mukeshkumar Vekaria and 6 more are mutual person
-
Colt Hydromatics Llp
Mukeshkumar Vekaria, Jaysukhbhai Sangani and 1 more are mutual person
-
Sharda Organiser & Buildcon Private Limited
Mukeshkumar Vekaria is a mutual person
-
Odhav Estate Infrastructure Development Limited
Mukeshkumar Vekaria is a mutual person
-
Allurich Minerals India Private Limited
Jayantilal Bhuva is a mutual person
Charges (Loans)
₹2.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 2.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2021 | Indian Bank | ₹2.75 Cr | Open |
How Many Employees Work at Cropel Lifesciences?
Cropel Lifesciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cropel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropel Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.